Strong Buy of the Month Review - EYET
Since recommending Eyetech Pharmaceuticals on July 18th, the stock has enjoyed a 25% gain resting around $14/share today. Earlier this week, the stock soared as high as $15.65 before some predictable profit-taking took place. Even after these healthy gains, we remain bullish on the long-term prospects of Eyetech.
Check back next week for August's Strong Buy of the Month pick.